Bliss GVS Pharma Ltd
NSE:BLISSGVS
Bliss GVS Pharma Ltd
NSE:BLISSGVS
Price:
213.28
INR
1.1%
Market Closed
Market Cap:
₹22.6B
Cash Flow Statement
Cash Flow Statement
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
1 424
|
1 116
|
1 041
|
1 202
|
1 278
|
1 061
|
1 868
|
1 461
|
1 311
|
1 256
|
1 636
|
|
| Depreciation & Amortization |
126
|
149
|
172
|
173
|
173
|
187
|
313
|
264
|
276
|
294
|
320
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
39
|
0
|
38
|
0
|
41
|
0
|
|
| Other Non-Cash Items |
(16)
|
(3)
|
291
|
434
|
(490)
|
392
|
442
|
118
|
185
|
389
|
436
|
|
| Cash Taxes Paid |
388
|
343
|
286
|
273
|
339
|
446
|
602
|
349
|
375
|
366
|
376
|
|
| Cash Interest Paid |
48
|
62
|
63
|
48
|
30
|
63
|
102
|
61
|
55
|
68
|
87
|
|
| Change in Working Capital |
(1 080)
|
(332)
|
(864)
|
(1 386)
|
394
|
(1 297)
|
(1 330)
|
(318)
|
(722)
|
(881)
|
(1 034)
|
|
| Cash from Operating Activities |
453
N/A
|
930
+105%
|
640
-31%
|
423
-34%
|
1 355
+221%
|
343
-75%
|
1 293
+277%
|
1 524
+18%
|
1 051
-31%
|
1 059
+1%
|
1 359
+28%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(603)
|
(41)
|
(91)
|
(520)
|
(740)
|
(938)
|
(1 114)
|
(283)
|
(449)
|
(763)
|
(714)
|
|
| Other Items |
114
|
(710)
|
(379)
|
644
|
(190)
|
860
|
506
|
(1 045)
|
(568)
|
8
|
(93)
|
|
| Cash from Investing Activities |
(490)
N/A
|
(751)
-53%
|
(470)
+37%
|
124
N/A
|
(930)
N/A
|
(78)
+92%
|
(608)
-684%
|
(1 328)
-118%
|
(1 018)
+23%
|
(754)
+26%
|
(807)
-7%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
16
|
23
|
20
|
31
|
23
|
32
|
29
|
21
|
|
| Net Issuance of Debt |
136
|
13
|
(89)
|
(424)
|
(177)
|
(152)
|
(246)
|
(117)
|
(119)
|
(210)
|
(471)
|
|
| Cash Paid for Dividends |
(125)
|
(125)
|
(55)
|
(55)
|
(53)
|
(54)
|
(107)
|
(54)
|
(54)
|
(54)
|
(55)
|
|
| Other |
(49)
|
(69)
|
(63)
|
(41)
|
(30)
|
(63)
|
(90)
|
(61)
|
(60)
|
(68)
|
(93)
|
|
| Cash from Financing Activities |
(38)
N/A
|
(181)
-372%
|
(208)
-15%
|
(505)
-143%
|
(237)
+53%
|
(249)
-5%
|
(411)
-65%
|
(209)
+49%
|
(201)
+4%
|
(303)
-51%
|
(598)
-97%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
78
|
1
|
16
|
43
|
(99)
|
14
|
(69)
|
(2)
|
83
|
1
|
(2)
|
|
| Net Change in Cash |
3
N/A
|
(0)
N/A
|
(22)
-7 250%
|
85
N/A
|
89
+4%
|
30
-66%
|
204
+576%
|
(14)
N/A
|
(85)
-504%
|
2
N/A
|
(47)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(150)
N/A
|
889
N/A
|
548
-38%
|
(98)
N/A
|
615
N/A
|
(595)
N/A
|
179
N/A
|
1 241
+593%
|
601
-52%
|
296
-51%
|
645
+118%
|
|
Switch to:
Switch to:
See Also
Discover More
